GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Works Technologies AB (XSAT:BIOWKS) » Definitions » Gross Margin %

Bio-Works Technologies AB (XSAT:BIOWKS) Gross Margin % : 85.94% (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Bio-Works Technologies AB Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Bio-Works Technologies AB's Gross Profit for the six months ended in Jun. 2024 was kr11.18 Mil. Bio-Works Technologies AB's Revenue for the six months ended in Jun. 2024 was kr13.01 Mil. Therefore, Bio-Works Technologies AB's Gross Margin % for the quarter that ended in Jun. 2024 was 85.94%.

Warning Sign:

Bio-Works Technologies AB gross margin has been in long-term decline. The average rate of decline per year is -7.5%.


The historical rank and industry rank for Bio-Works Technologies AB's Gross Margin % or its related term are showing as below:

XSAT:BIOWKS' s Gross Margin % Range Over the Past 10 Years
Min: 58.28   Med: 93.52   Max: 278.02
Current: 70.03


During the past 9 years, the highest Gross Margin % of Bio-Works Technologies AB was 278.02%. The lowest was 58.28%. And the median was 93.52%.

XSAT:BIOWKS's Gross Margin % is ranked better than
62.47% of 746 companies
in the Biotechnology industry
Industry Median: 60.565 vs XSAT:BIOWKS: 70.03

Bio-Works Technologies AB had a gross margin of 85.94% for the quarter that ended in Jun. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Bio-Works Technologies AB was -7.50% per year.


Bio-Works Technologies AB Gross Margin % Historical Data

The historical data trend for Bio-Works Technologies AB's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Works Technologies AB Gross Margin % Chart

Bio-Works Technologies AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only 96.36 58.28 84.71 69.81 61.10

Bio-Works Technologies AB Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.47 67.73 61.65 60.55 85.94

Competitive Comparison of Bio-Works Technologies AB's Gross Margin %

For the Biotechnology subindustry, Bio-Works Technologies AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Works Technologies AB's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Works Technologies AB's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Bio-Works Technologies AB's Gross Margin % falls into.



Bio-Works Technologies AB Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Bio-Works Technologies AB's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=26.8 / 43.896
=(Revenue - Cost of Goods Sold) / Revenue
=(43.896 - 17.075) / 43.896
=61.10 %

Bio-Works Technologies AB's Gross Margin for the quarter that ended in Jun. 2024 is calculated as


Gross Margin % (Q: Jun. 2024 )=Gross Profit (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=11.2 / 13.014
=(Revenue - Cost of Goods Sold) / Revenue
=(13.014 - 1.83) / 13.014
=85.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Bio-Works Technologies AB  (XSAT:BIOWKS) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Bio-Works Technologies AB had a gross margin of 85.94% for the quarter that ended in Jun. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Bio-Works Technologies AB Gross Margin % Related Terms

Thank you for viewing the detailed overview of Bio-Works Technologies AB's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Works Technologies AB Business Description

Traded in Other Exchanges
N/A
Address
Virdings alle 18, Uppsala, SWE, 75450
Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for purification and separation of proteins and other molecules. The product line of the company includes activated resin, immobilized metal-ion affinity chromatography resin, ion exchange chromatography resin, size exclusion chromatography resin and others. The company has also developed affinity chromatography technique, BabyBio Columns, OptiBio glass columns for separating proteins, and protein purification. Bio-Works serves various end users such as academic research laboratories, biopharmaceutical companies, the food and beverage industry and others.

Bio-Works Technologies AB Headlines

No Headlines